SONOMA PHARMACEUTICALS, INC. License and Services Revenue (Deprecated 2018-01-31)
SONOMA PHARMACEUTICALS, INC. (SNOA) reported License and Services Revenue (Deprecated 2018-01-31) of $11.96 million for the 12-month period ending 2017-03-31, per its 10-K filed 2017-06-28.
Discontinued › Income Statement › Other Income
us-gaap:LicenseAndServicesRevenue · last filed 2017-06-28
- SONOMA PHARMACEUTICALS, INC. license and services revenue (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $3.80M, a 60.36% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. license and services revenue (deprecated 2018-01-31) for the quarter ending 2016-12-31 was $3.71M, a 64.63% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. license and services revenue (deprecated 2018-01-31) for the quarter ending 2016-09-30 was $3.88M, a 3.77% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. license and services revenue (deprecated 2018-01-31) for the quarter ending 2016-06-30 was $3.58M, a 6.57% increase year-over-year.
- SONOMA PHARMACEUTICALS, INC. license and services revenue (deprecated 2018-01-31) for fiscal 2017 was $11.96M, a 43.92% increase from fiscal 2016.
- SONOMA PHARMACEUTICALS, INC. license and services revenue (deprecated 2018-01-31) for fiscal 2016 was $8.31M, a 36.07% decline from fiscal 2015.
- SONOMA PHARMACEUTICALS, INC. license and services revenue (deprecated 2018-01-31) for fiscal 2015 was $12.99M, a 2.14% increase from fiscal 2014.
- SONOMA PHARMACEUTICALS, INC. license and services revenue (deprecated 2018-01-31) for fiscal 2014 was $12.72M.
| Period end | License and Services Revenue (Deprecated 2018-01-31) 3 month | License and Services Revenue (Deprecated 2018-01-31) 3 month as first filed | License and Services Revenue (Deprecated 2018-01-31) 6 month | License and Services Revenue (Deprecated 2018-01-31) 9 month | License and Services Revenue (Deprecated 2018-01-31) 9 month as first filed | License and Services Revenue (Deprecated 2018-01-31) 12 month | License and Services Revenue (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2017-03-31 | $3.80M derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-28 | $7.51M derived: sum of 2 quarters · filed 2017-06-28 | $11.40M derived: sum of 3 quarters · filed 2017-06-28 | $11.96M 10-K · filed 2017-06-28 | |||
| 2016-12-31 | $3.71M 10-Q · filed 2017-02-17 | $7.60M derived: sum of 2 quarters · filed 2017-02-17 | $8.16M 10-Q · filed 2017-02-17 | $13.55M derived: sum of 4 quarters · filed 2017-06-28 | |||
| 2016-09-30 | $3.88M 10-Q · filed 2016-11-15 | $7.47M 10-Q · filed 2016-11-15 | $9.84M derived: sum of 3 quarters · filed 2017-06-28 | $12.09M derived: sum of 4 quarters · filed 2017-06-28 | |||
| 2016-06-30 | $3.58M 10-Q · filed 2016-08-09 | $5.95M derived: sum of 2 quarters · filed 2017-06-28 | $8.21M derived: sum of 3 quarters · filed 2017-06-28 | $11.95M derived: sum of 4 quarters · filed 2017-06-28 | |||
| 2016-03-31 | $2.37M derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-28 | $4.63M derived: sum of 2 quarters · filed 2017-06-28 | $8.37M derived: sum of 3 quarters · filed 2017-06-28 | $8.31M 10-K · filed 2017-06-28 | $14.02M 10-K · filed 2016-06-21 | ||
| 2015-12-31 | $2.26M 10-Q · filed 2017-02-17 | $3.59M 10-Q · filed 2016-02-16 | $6.00M derived: sum of 2 quarters · filed 2017-02-17 | $5.94M 10-Q · filed 2017-02-17 | $10.70M 10-Q · filed 2016-02-16 | $13.09M derived: sum of 4 quarters · filed 2017-02-17 | |
| 2015-09-30 | $3.74M 10-Q · filed 2016-11-15 | $7.11M 10-Q · filed 2016-11-15 | $10.83M derived: sum of 3 quarters · filed 2016-11-15 | $13.86M derived: sum of 4 quarters · filed 2016-11-15 | |||
| 2015-06-30 | $3.36M 10-Q · filed 2016-08-09 | $7.09M derived: sum of 2 quarters · filed 2016-08-09 | $10.12M derived: sum of 3 quarters · filed 2016-08-09 | $13.19M derived: sum of 4 quarters · filed 2016-08-09 | |||
| 2015-03-31 | $3.72M derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-21 | $6.75M derived: sum of 2 quarters · filed 2016-06-21 | $9.82M derived: sum of 3 quarters · filed 2016-06-21 | $12.99M 10-K · filed 2016-06-21 | |||
| 2014-12-31 | $3.03M 10-Q · filed 2016-02-16 | $6.10M derived: sum of 2 quarters · filed 2016-02-16 | $9.27M 10-Q · filed 2016-02-16 | ||||
| 2014-09-30 | $3.07M 10-Q · filed 2015-11-10 | $6.24M 10-Q · filed 2015-11-10 | |||||
| 2014-06-30 | $3.17M 10-Q · filed 2015-08-07 | ||||||
| 2014-03-31 | $12.72M 10-K · filed 2015-06-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |